Atossa Therapeutics, Inc. (ATOS)
USD 0.99
(-4.81%)
USD 0.99
(-4.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -20.94 Thousand | -20.76 Million | -16.47 Million | -11.57 Million | -9.12 Million | -8.96 Million |
| Net Income | -30.09 Thousand | -26.96 Million | -20.6 Million | -17.82 Million | -17.23 Million | -11.4 Million |
| Depreciation & Amortization | 23.00 | 8000.00 | 23 Thousand | 46.52 Thousand | 52.78 Thousand | 44.19 Thousand |
| Deferred income taxes | 1.07 Million | - | -5.62 Million | 2.36 Million | - | - |
| Stock-based compensation | 4621.00 | 6788.00 | 5267.00 | 3.01 Million | 8.84 Million | 2.46 Million |
| Change in working capital | 3678.00 | -599 Thousand | -1.15 Million | -111.35 Thousand | -791.29 Thousand | -64.4 Thousand |
| Other non-cash items | 831.00 | 3000.00 | 5.62 Million | 938.79 Thousand | 5806.00 | 2.69 Million |
| Investing Cash Flow | -14.00 | -4.72 Million | -9000.00 | -9367.00 | -7625.00 | -110.9 Thousand |
| Investments in PPE | -14.00 | -27 Thousand | -9000.00 | -9367.00 | -7625.00 | -110.9 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -4.7 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -4700.00 | -9000.00 | -9367.00 | -7625.00 | -110.9 Thousand |
| Financing Cash Flow | -1475.00 | - | 113.3 Million | 38.55 Million | 11.33 Million | 12.29 Million |
| Debt repayment | - | - | - | -14 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1475.00 | - | -573.00 | -14 Thousand | - | - |
| Common Stock Issuance | - | - | 113.87 Million | 33.61 Million | 11.33 Million | 12.29 Million |
| Other Financing Activities | - | - | -573 Thousand | 9.46 Million | 11.33 Million | 12.29 Thousand |
| Accounts receivables | 743 Thousand | 329 Thousand | -437 Thousand | 104.71 Thousand | -221.55 Thousand | -159.82 Thousand |
| Accounts payables | -2.15 Million | 1.24 Million | 128 Thousand | 1.29 Million | -60.15 Thousand | 18.42 Thousand |
| Inventory | 2.54 Million | -329 Thousand | 437 Thousand | -104.71 Thousand | 221.55 Thousand | - |
| Other working capital | 3678.00 | -1.84 Million | -1.28 Million | -1.4 Million | -731.14 Thousand | -82.83 Thousand |
| Cash at beginning of period | 111 Thousand | 136.48 Million | 39.66 Million | 12.69 Million | 10.49 Million | 7.27 Million |
| Cash at end of period | 88.57 Thousand | 111 Million | 136.48 Million | 39.66 Million | 12.69 Million | 10.49 Million |
| Capital Expenditure | -14.00 | -27 Thousand | -9000.00 | -9367.00 | -7625.00 | -110.9 Thousand |
| Effect of forex changes on cash | 22.4 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -22.43 Thousand | -25.48 Million | 96.82 Million | 26.97 Million | 2.2 Million | 3.21 Million |
| Free Cash Flow | -20.95 Thousand | -20.78 Million | -16.48 Million | -11.57 Million | -9.13 Million | -9.07 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.04 Million | -5.87 Million | -30.09 Million | -7.75 Million | -6.22 Million | -9.83 Million |
| Depreciation & Amortization | 4000.00 | 5000.00 | 23 Thousand | 14 Thousand | 3000.00 | 3000.00 |
| Deferred income taxes | - | - | 1.07 Million | 87.48 Thousand | -527 Thousand | - |
| Stock-based compensation | 352 Thousand | 417 Thousand | 4621.00 | 519 Thousand | 926 Thousand | 1.6 Million |
| Change in working capital | 1.16 Million | 756 Thousand | 1.51 Million | 1.65 Million | 1.41 Million | 769 Thousand |
| Other non-cash items | 536 Thousand | 5000.00 | 6.52 Million | 431 Thousand | 527 Thousand | 2.99 Million |
| Investing Cash Flow | -3000.00 | -6000.00 | -14 Thousand | - | -1000.00 | -13 Thousand |
| Investments in PPE | -3000.00 | -6000.00 | -14 Thousand | - | -1000.00 | -13 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 100 Thousand | 204 Thousand | -1.47 Million | - | -1.47 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -1.47 Million | - | -1.47 Million | - |
| Common Stock Issuance | 100 Thousand | 204 Thousand | - | - | - | - |
| Other Financing Activities | 100 Thousand | 204 Thousand | - | - | - | - |
| Accounts receivables | - | - | 743 Thousand | 28 Thousand | 709 Thousand | 1000.00 |
| Accounts payables | -174 Thousand | 424 Thousand | -2.15 Million | 88 Thousand | -304 Thousand | -422 Thousand |
| Inventory | - | - | 2.54 Million | 2.54 Million | -709 Thousand | -1000.00 |
| Other working capital | 1.33 Million | 332 Thousand | 391 Thousand | -1.01 Million | 1.72 Million | 1.19 Million |
| Cash at beginning of period | 84.07 Million | 88.57 Million | 111 Million | 94.14 Million | 99.5 Million | 103.97 Million |
| Cash at end of period | 79.63 Million | 84.07 Million | 88.57 Million | 88.57 Million | 94.14 Million | 99.5 Million |
| Capital Expenditure | -3000.00 | -6000.00 | -14 Thousand | - | -1000.00 | -13 Thousand |
| Effect of forex changes on cash | - | - | 22.4 Million | -23.58 Million | 19.11 Million | 4.47 Million |
| Net cash flow / Change in cash | -4.43 Million | -4.5 Million | -22.43 Million | -5.57 Million | -5.35 Million | -4.47 Million |
| Free Cash Flow | -4.53 Million | -4.7 Million | -20.95 Million | -5.57 Million | -3.88 Million | -4.47 Million |
6578
ORA
IIJIF
2375
UNCRY
ATONY